OnKure (OKUR): Market Valuation

Graphic logo of OnKure Therapeutics Inc (OKUR)

The market trend for OnKure Therapeutics Inc (OKUR) demonstrates a capitalization of 0.11. The business is building a precision oncology network by implementing advanced HDAC inhibitors to combat tumor resistance. Environmental impact is minimal, limited only to the strict control of laboratory waste. The patents for the OKI-179 molecule are particularly valuable, as it specifically targets breast cancer mutations, providing the company with immense pricing power.

OKUR OnKure Therapeutics: Market Value in the range 10/08/2024 - 11/18/2026

Metric breakdowns and analytics for OnKure Therapeutics, Inc. (OKUR)

Fundamental company valuation:OnKure Therapeutics OKUR
Product sample of OnKure Therapeutics

Investing in OnKure Therapeutics Inc (OKUR) requires a strict fundamental approach to valuation. Market capitalization is determined by the product of the current share price and the total number of outstanding securities. By analyzing the issuer's aggregate capitalization, an investor separates market noise from real business dynamics. This indicator reflects the market value of the company's exclusive patent rights and FDA protocols. High technological barriers make this capital resilient to competition.

Competitors of OnKure Therapeutics Inc (OKUR)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|HURA: Market Value|Market Valuation TARA (Protara)|FATE (Fate Therapeutics Corp) - Market Value|Market Capitalization WHWK (Aadi Bioscience Inc)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|CVM: Market Capitalization|OS Therapies Inc - Market Value|RADX (radiopharmtheranostics.com) - Market Capitalization|Market Value Artiva Biotherapeutics, Inc. ARTV|Market Capitalization ANL|Market Value VERU (Veru)|Market Capitalization TPST (tempesttx.com)|Xilio - Market Value|RENB - Market Value|Market Value MURA (muraloncology.com)|Kairos Pharma Inc (KAPA) - Market Value|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group